Ankylosing spondylitis, Budget impact, Cost-effectiveness, Cost-utility, Discrete event simulation, Health impact, Microsimulation, Modelling, Population dynamics, Tumor necrosis factor,
Cost Effectiveness and Resource Allocation
Erasmus School of Health Policy & Management (ESHPM)

Tran-Duy, A, Boonen, A, van de Laar, M.A.F.J, & Severens, J.L. (2015). Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: A dynamic population modelling study. Cost Effectiveness and Resource Allocation, 13(1). doi:10.1186/s12962-015-0044-x